9-117029-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_207305.5(FOXD4):c.1091A>C(p.Gln364Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000102 in 1,611,946 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_207305.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152254Hom.: 0 Cov.: 34
GnomAD3 exomes AF: 0.0000358 AC: 9AN: 251108Hom.: 0 AF XY: 0.0000516 AC XY: 7AN XY: 135722
GnomAD4 exome AF: 0.000109 AC: 159AN: 1459692Hom.: 0 Cov.: 37 AF XY: 0.000106 AC XY: 77AN XY: 726156
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152254Hom.: 0 Cov.: 34 AF XY: 0.0000538 AC XY: 4AN XY: 74382
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.1091A>C (p.Q364P) alteration is located in exon 1 (coding exon 1) of the FOXD4 gene. This alteration results from a A to C substitution at nucleotide position 1091, causing the glutamine (Q) at amino acid position 364 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at